Ginkgo Bioworks Holdings Inc vs PubMatic Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while PubMatic Inc trades at $17.52 (market cap $804.41M). The key difference: PubMatic Inc is the larger of the two by market cap, and PubMatic Inc is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.
| DNA | PUBM | |
|---|---|---|
Market Cap | $505.73M | $804.41M |
Sector | Health | Technology |
52-Week High | $16.14 | $17.78 |
52-Week Low | $5.48 | $6.28 |
Enterprise Value | $607.68M | $707.54M |
Trailing returns across standard periods
Latest headlines on both assets
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →PubMatic Inc is engaged in the digital advertising business. The company provides a specialized cloud infrastructure platform that enables real-time programmatic advertising transactions. The platform helps independent app developers and publishers to control and maximize their digital advertising businesses.
Read more on PUBM →